Synergy Pharmaceuticals to Present at 2010 GHS Healthcare Conference
12. August 2010 07:30 ET
|
Synergy Pharmaceuticals
NEW YORK--Synergy Pharmaceuticals, Inc. (OTC BB: SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced today that Dr. Gary S. Jacob, the Company's President...
Callisto Pharmaceuticals Adjourns Annual Stockholders Meeting Due to Lack of a Quorum
12. Juli 2010 08:00 ET
|
Synergy Pharmaceuticals
NEW YORK--Callisto Pharmaceuticals, Inc. (OTCBB: CLSP.OB), announced today that it adjourned its annual stockholders' meeting held on July 9, 2010 due to lack of a quorum. The agenda for the...
Synergy Pharmaceuticals to Present at 2010 BIO Business Forum in Chicago, IL
27. April 2010 07:15 ET
|
Synergy Pharmaceuticals
2010 BIO International Convention
NEW YORK--Synergy Pharmaceuticals, Inc. (OTC BB:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced today that Dr. Gary S....
Synergy Pharmaceuticals Initiates Phase IIa Clinical Trial of SP-304 in Patients with Chronic Constipation
19. März 2010 08:15 ET
|
Synergy Pharmaceuticals
NEW YORK--Synergy Pharmaceuticals, Inc. (OTC BB:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced today the initiation of dosing in a Phase IIa clinical...
Synergy Pharmaceuticals to Present at the 8th Annual BioPartnering North America (BPN) Conference in Vancouver, BC, Canada
22. Januar 2010 08:15 ET
|
Synergy Pharmaceuticals
BioPartnering North America 2010
NEW YORK--Synergy Pharmaceuticals, Inc. (OTC BB: SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced today that Dr. Gary S....
Synergy Pharmaceuticals Raises $8.6 Million in Common Stock Financing
12. November 2009 08:15 ET
|
Synergy Pharmaceuticals
NEW YORK--Synergy Pharmaceuticals, Inc. (OTC BB: SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced today that it has completed a private placement in which...
Synergy Pharmaceuticals Announces Appointment of Dr. Alan F. Joslyn to Board of Directors
08. Oktober 2009 08:30 ET
|
Synergy Pharmaceuticals
NEW YORK--Synergy Pharmaceuticals, Inc. (OTC BB: SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced today that on October 6, 2009 the Board of Directors of...
Synergy Pharmaceuticals to Present at the 17th Annual BioPartnering Europe Conference in London, UK
05. Oktober 2009 08:30 ET
|
Synergy Pharmaceuticals
BioPartnering Europe 2009
NEW YORK--Synergy Pharmaceuticals, Inc. (OTCBB: SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced today that management will...
Synergy Pharmaceuticals Raises $7.09 Million in Common Stock Financing
07. Juli 2009 07:15 ET
|
Synergy Pharmaceuticals
NEW YORK--Synergy Pharmaceuticals, Inc. (OTC BB:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced today that it has completed the final tranche of its...
Synergy Pharmaceuticals to Present Phase I Volunteer Study on SP-304 Investigational Drug to Treat GI Disorders at Upcoming Conference
26. Mai 2009 04:01 ET
|
Synergy Pharmaceuticals
NEW YORK--Synergy Pharmaceuticals, Inc. (OTC BB: SGYP.OB SGY PNews), a developer of new drugs to treat gastrointestinal disorders and diseases, announced today that clinical data from the Phase I...